Description
AOD9604, short for “Anti-Obesity Drug 9604,” is a synthetic peptide fragment derived from the C-terminal region of human growth hormone (hGH). It consists of amino acids 176 through 191 of hGH, with an additional tyrosine residue at the N-terminus. Its molecular formula is C78H123N23O23S2, and it has a molecular weight of approximately 1815.12 g/mol. The peptide contains a disulfide bridge between two cysteine residues, which stabilizes its three-dimensional structure.
AOD9604 was first developed in the 1990s. The goal was to isolate the region of growth hormone of interest to metabolic researchers while excluding the remainder of the full-length hormone sequence. It is classified as a modified peptide fragment and is supplied as a white to off-white lyophilized (freeze-dried) powder that is readily soluble in water. The U.S. FDA granted it GRAS (Generally Recognized As Safe) status in 2014 as a food ingredient.
This product is strictly for research purposes only. Not approved for human or animal use.
PubChem Reference: View compound profile on NIH PubChem
Key Characteristics
MOLECULAR PROFILE
Formula: C78H123N23O23S2
Weight: 1815.12 g/mol
Origin: HGH Fragment 176-191 + Tyrosine
Structure: Modified peptide with disulfide bridge
PHYSICAL PROPERTIES
Form: White to off-white lyophilized powder
Solubility: Readily soluble in water
Stability: Excellent with disulfide bridge
Storage: Keep refrigerated 36‑46 °F (2‑8 °C)





Reviews
There are no reviews yet.